Notice Number: NOT-DA-18-028
Key Dates
Release Date: July 19, 2018
RFA-DA-18-019
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this notice is to inform interested applicants of a correction to the Letters of Reference submission deadline for RFA-DA-18-019 "NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)". Specifically, the deadline for submitting letters of reference is 5:00 p.m. (local time of applicant organization), August 14, which is the Application Due Date.
Section IV. Application Submission Information
7. Other Submission Requirements and Information
Letters of Reference
Currently Reads:
The letter of reference submission deadline: The deadline for receipt of letters is 5:00 p.m. (local time of the referee) on the Application Due Date of the competition, July 31. Letters must be submitted to the Commons at (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new) by 5:00 p.m. (local time of the referee), on the Application Due Date of the competition, Aug. dd. |
Modified to Read:
The letter of reference submission deadline: The deadline for receipt of letters is 5:00 p.m. (local time of the referee) on the Application Due Date of the competition, August 14. Letters must be submitted to the Commons at (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new) by 5:00 p.m. (local time of the referee), on the Application Due Date of the competition, Aug. 14. |
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Redonna Chandler, PhD
National Institute on Drug Abuse
Telephone: 301-402-1919
Email: [email protected]
and Human Services (HHS)
